Jan Skvarka - Sep 9, 2022 Form 3 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
/s/ Andrea Paul, attorney-in-fact for Jan Skvarka
Stock symbol
ZNTL
Transactions as of
Sep 9, 2022
Transactions value $
$0
Form type
3
Date filed
9/12/2022, 07:06 AM
Previous filing
Nov 19, 2021
Next filing
Mar 24, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney